The St. Vincent Research and Regulatory Affairs will be hosting the 9th Annual St. Vincent Health Research Symposium next month. This daylong event will feature keynote speakers, William Droegemueller, MD, Distinguished Clinical Professor, Obstetrics and Gynecology at...
TransCelerate BioPharma which is an intriguing new big pharma collaboration was recently launched at a US trade show with the intentions of expediting the clinical research process. According to a recent article from Outsourcing-pharma.com , there are “five...
The European Medicines Agency provided draft guidance documents focused on the quality of oral modified release products and transdermal delivery patches last week. The EMA anticipates a response by March 2013. The guidelines for patches are fixed toward developers...
Today, we announced some very exciting news. Pearl IRB has grown. To meet the needs of our clients, we have expanded our service offerings. Pearl Pathways, the new parent company, will be organized into three distinct and efficient business units. Pearl IRB remains...
A recent article on Medical News Today’s website entitled “FDA Takes ‘First Step’ Toward Greater Regulatory Certainty Around Nanotechnology” reviews FDA’s June 9th release of a draft guidance that provides regulated industries with greater...
